Navigation Links
Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
Date:1/28/2009

Pace is expected to enter a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia early in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 clinical trial for the treatment of heart failure early in 2009. In addition, Cordex has a preclinical program to develop new chemical entities that target a recently discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For further information regarding Cordex, please visit the company's website at www.cordexpharma.com.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Cordex intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. All statements in this release regarding the future outlook related to Cordex are forward-looking statements, including, but not limited to, the statements regarding ATPace's expected entry into a pivotal Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, CDP-1050's expected commencement of a Phase 2 clinical trial for the treatment of heart failure and our intent to write a new chapter in the development of proprietary pharmaceuticals that treat urgent medical needs. The forward-looking statements are subject to risks and uncertainti
'/>"/>

SOURCE Duska Therapeutics, Inc.; Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Duska Therapeutics Applies for Phase 3 Special Protocol Assessment
2. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
3. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
4. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
7. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
8. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
9. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
10. Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis
11. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets ... Type of Material, by Technology, by Application & by Region- ... offering. The demand for membranes is estimated ... the market to $29.31 billion Membrane technology was ... such as water filtration and kidney dialysis. In modern times, ...
(Date:8/19/2014)... , Aug. 19, 2014 Avizia, Inc., ... that it has closed an equity financing round led ... Middleland Capital. The new funding will be used to ... this financing round, Avizia welcomes Edward Kennedy , ... of directors. He joins Leonard Kurtzman , CFO ...
(Date:8/19/2014)... Calif. , Aug. 19, 2014  Cardiva Medical, ... two tranches of a $16.5 million Series 3 private ... with GE Capital. The Company will use the proceeds ... facility to expand commercial efforts for its VASCADE® Vascular ... . Investing in Series 3 private ...
Breaking Medicine Technology:Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Avizia Closes Funding Round 2Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
... Inhibitex, Inc. (Nasdaq: INHX ) today announced that ... its common stock, at a purchase price of $4.10 per ... proceeds to Inhibitex from the sale of the shares, after ... to be approximately $44 million.  Inhibitex has granted the underwriters ...
... April 7, 2011 Vystar® Corporation ... Rubber Latex (NRL), a patented, all-natural raw latex ... non-rubbers found in natural rubber latex, has appointed ... (Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO) Ms. Kearney is ...
Cached Medicine Technology:Inhibitex Prices $47 Million Public Offering 2Inhibitex Prices $47 Million Public Offering 3Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 2Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 3
(Date:8/20/2014)... at the Universities of Manchester and Auckland suggest that both ... mechanism. , The findings, published today in the ... or type-1 diabetes and type-2 diabetes are both caused by ... , The results, based on 20 years, work ... both be slowed down and potentially reversed by medicines that ...
(Date:8/20/2014)... VA (PRWEB) August 20, 2014 ... nation’s leading nonprofit authority on the use of ... exchange, announced the full agenda for its annual ... Health IT Efficiency. WEDI-Con 2014 will take place ... October 20-23, 2014, attracting a diverse cross-section of ...
(Date:8/20/2014)... The National Association of Hispanic ... Science Education Partnership Award (SEPA) grant from the ... project with the Hispanic Communications Network (HCN) entitled ... collaborative NIH R25 program has been established to ... among health professionals by recruiting and interviewing bilingual ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Attendees of ... a sneak peak at Los Angeles’ first multi-faceted food ... tour of a blossoming 1.5-acre high school campus urban ... shipping container farm in the L.A. Art District. , ... of sustainable urban agriculture, will kick off Seedstock’s “Reintegrating ...
(Date:8/20/2014)... Charlotte, North Carolina (PRWEB) August 20, 2014 ... BBC , findings from a University College London (UCL) ... drastically disagreed on what method of brushing teeth was ... worldwide found that six different tooth-brushing techniques were frequently ... At the Charlotte Center for Cosmetic Dentistry, experienced ...
Breaking Medicine News(10 mins):Health News:Scientists show type-1 and type-2 diabetes are caused by same underlying mechanism 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3Health News:Seedstock Sustainable Agriculture Conference’s Urban Farm Field Trip to Offer First Look at Los Angeles’ Premier Food Business Incubator 2Health News:Seedstock Sustainable Agriculture Conference’s Urban Farm Field Trip to Offer First Look at Los Angeles’ Premier Food Business Incubator 3Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3
... , RANCHO SANTA FE, Calif., Dec. 22 ... Helen Woodward Animal Center (HWAC) began a quest to change the ... Animal Sanctuary the HWAC team from Rancho Santa Fe, CA learned ... Society facility on the island only three of the 120 dogs ...
... ... a comprehensive New Jersey anti-poverty charity, seeks year-end charitable contributions to meet an increasing need. ... Paterson, NJ (PRWEB) December ... Jersey during the current economic recession. By giving a charitable contribution to this trustworthy ...
... Ecumen applies hospitality ... ... development expert for Ecumen , Julie Murray spent the better part of her ... the Caribbean. , , ,Murray sees multiple parallels between providing hospitality in the expanding ...
... in the January issue of Radiology , 42 percent ... to undergo the procedure. "Given that MRI is ... cancer, we were surprised that barely half of women at ... offered at no cost," said Wendie A. Berg, M.D., Ph.D., ...
... , ANNAPOLIS, Md., Dec. 21 SCLogic, ... today announced the donation of its SCL Intra (TM) package ... a donation of a Motorola MC55 Enterprise Digital Assistant (EDA). ... in Florida designed for children with life-threatening illnesses, will use ...
... , , , , CHARLOTTE, N.C., Dec. 21 ... announced today it is investing in industry-leading technology in both ... marketplace. , (Logo: http://www.newscom.com/cgi-bin/prnh/20080903/CLW036LOGO-b ) , ... the U.S. and China. Construction associated with the projects is ...
Cached Medicine News:Health News:While Some Were Counting Sugar Plums...Others Were Changing the Future 2Health News:Eva's Village, a Paterson, New Jersey Anti-Poverty Charity, Seeks End of Year Charitable Contributions to Help Poor in a Troubled Economy 2Health News:Eva's Village, a Paterson, New Jersey Anti-Poverty Charity, Seeks End of Year Charitable Contributions to Help Poor in a Troubled Economy 3Health News:Ecumen Provides 10 Tips to Make Senior Housing a Cruise Ship on Land 2Health News:Ecumen Provides 10 Tips to Make Senior Housing a Cruise Ship on Land 3Health News:Ecumen Provides 10 Tips to Make Senior Housing a Cruise Ship on Land 4Health News:Elevated-risk women refuse MRI breast cancer screening 2Health News:SCLogic Donates Mobile Enterprise Tracking Solution to Give Kids The World Village 2Health News:PGI To Invest in Nonwovens Technology in U.S. and Asia to Serve Hygiene and Healthcare Markets 2Health News:PGI To Invest in Nonwovens Technology in U.S. and Asia to Serve Hygiene and Healthcare Markets 3
... design and reduced dimensions provide ... control of IOL while grasping ... the optic. Curved shafts with ... curved. Smooth, flat, cross action ...
... implanting the haptic loop beneath the ... bag without wrist twisting. Angled 45 ... placed in the same vertical plane ... action handle with dull finish. Most ...
Smooth colibri tip used to grasp and subsequently retract the capsule during nucleus delivery. Serrated handle with polished finish....
Two rows of teeth on jaws provide a firm purchase on the nucleus fragment for removal. Flat handle with dull finish....
Medicine Products: